IL319012A - Heterocyclic sik inhibitors - Google Patents
Heterocyclic sik inhibitorsInfo
- Publication number
- IL319012A IL319012A IL319012A IL31901225A IL319012A IL 319012 A IL319012 A IL 319012A IL 319012 A IL319012 A IL 319012A IL 31901225 A IL31901225 A IL 31901225A IL 319012 A IL319012 A IL 319012A
- Authority
- IL
- Israel
- Prior art keywords
- heterocyclic
- sik inhibitors
- sik
- inhibitors
- heterocyclic sik
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263376480P | 2022-09-21 | 2022-09-21 | |
| PCT/IB2023/059215 WO2024062360A1 (en) | 2022-09-21 | 2023-09-18 | Heterocyclic sik inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319012A true IL319012A (en) | 2025-04-01 |
Family
ID=88197059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319012A IL319012A (en) | 2022-09-21 | 2023-09-18 | Heterocyclic sik inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20240124450A1 (en) |
| EP (1) | EP4590675B1 (en) |
| JP (1) | JP7826572B2 (en) |
| KR (1) | KR20250070082A (en) |
| CN (1) | CN119948025A (en) |
| AR (1) | AR130531A1 (en) |
| AU (1) | AU2023346248A1 (en) |
| CA (1) | CA3268028A1 (en) |
| CL (1) | CL2025000479A1 (en) |
| CO (1) | CO2025003311A2 (en) |
| CR (1) | CR20250098A (en) |
| DO (1) | DOP2025000069A (en) |
| FI (1) | FI4590675T3 (en) |
| IL (1) | IL319012A (en) |
| MX (1) | MX2025003324A (en) |
| PE (1) | PE20251177A1 (en) |
| PY (1) | PY2375863A (en) |
| TW (1) | TW202421625A (en) |
| WO (1) | WO2024062360A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3103304A1 (en) | 2018-06-15 | 2019-12-19 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| WO2025232877A1 (en) * | 2024-05-10 | 2025-11-13 | Insilico Medicine Ip Limited | Salt-inducible kinases (sik) inhibitors |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT901786E (en) | 1997-08-11 | 2007-08-07 | Pfizer Prod Inc | Solid pharmaceutical dispersions with enhanced bioavailability |
| CA2722418C (en) * | 2008-05-13 | 2013-09-17 | Irm Llc | Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| EP2993169B1 (en) | 2009-11-17 | 2017-12-20 | Novartis AG | Aryl-pyridine derivatives as aldosterone synthase inhibitors |
| LT2925757T (en) | 2012-11-19 | 2017-12-27 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| US9260426B2 (en) * | 2012-12-14 | 2016-02-16 | Arrien Pharmaceuticals Llc | Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors |
| JP6441830B2 (en) | 2013-03-14 | 2018-12-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Substituted 2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (cyano-methyl) -amide inhibitors of cathepsin C |
| GB2522226A (en) | 2014-01-17 | 2015-07-22 | Agency Science Tech & Res | Heteroaryl alkyne derivatives and uses thereof |
| TWI763722B (en) | 2016-10-14 | 2022-05-11 | 美商林伯士拉克許米公司 | Tyk2 inhibitors and uses thereof |
| CN110869756B (en) | 2017-07-10 | 2023-10-27 | 新东工业株式会社 | Surface characteristic evaluation method, surface characteristic evaluation device, and surface characteristic evaluation system |
| WO2019105886A1 (en) * | 2017-12-02 | 2019-06-06 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| CA3089762A1 (en) | 2018-01-29 | 2019-08-01 | Merck Patent Gmbh | Gcn2 inhibitors and uses thereof |
| EP3788050B1 (en) | 2018-05-01 | 2024-08-28 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mtor inhibitors |
| CA3103304A1 (en) * | 2018-06-15 | 2019-12-19 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| JP7576552B2 (en) | 2019-01-18 | 2024-10-31 | バイオジェン・エムエイ・インコーポレイテッド | Imidazo[1,2-a]pyridinyl derivatives and their use in the treatment of diseases - Patents.com |
| GB201907616D0 (en) * | 2019-05-29 | 2019-07-10 | Galapagos Nv | Novel compounds and pharmaceutical compositons thereof for the treatment of diseases |
| GB201907558D0 (en) * | 2019-05-29 | 2019-07-10 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| WO2020249096A1 (en) * | 2019-06-14 | 2020-12-17 | 南京明德新药研发有限公司 | Fused ring compound as fgfr and vegfr dual inhibitor |
| EP4003992A1 (en) | 2019-07-24 | 2022-06-01 | Merck Patent GmbH | 4-(imidazo[1,2-a]pyridin-3-yl) -pyrimidine derivatives |
| GB201915831D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
| GB201915829D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
| AR120982A1 (en) | 2020-01-06 | 2022-04-06 | Syngenta Crop Protection Ag | HETEROCYCLIC DERIVATIVES ACTIVE AS PESTICIDES WITH SUBSTITUENTS CONTAINING SULFUR |
| AU2021320860A1 (en) * | 2020-08-05 | 2023-02-23 | The General Hospital Corporation | Salt inducible kinase inhibitors |
| EP4284801A4 (en) * | 2021-02-01 | 2025-04-23 | Janssen Biotech, Inc. | Small molecule inhibitors of salt-inducible kinases |
| US20240174662A1 (en) * | 2021-02-01 | 2024-05-30 | Janssen Biotech, Inc. | Small molecule inhibitors of salt inducible kinases |
| CN115197208A (en) * | 2021-04-01 | 2022-10-18 | 江苏恒瑞医药股份有限公司 | Heteroaryl compound, preparation method and application thereof in medicine |
| CN113336751A (en) * | 2021-05-31 | 2021-09-03 | 南京谷睿生物科技有限公司 | High-efficiency salt-induced kinase inhibitor and preparation method thereof |
| CN115448881A (en) * | 2021-06-09 | 2022-12-09 | 江苏恒瑞医药股份有限公司 | Heteroaryl compound, preparation method and application thereof in medicine |
| CN118119619A (en) * | 2021-10-18 | 2024-05-31 | 上海美悦生物科技发展有限公司 | SIK inhibitor and composition, preparation method and application thereof |
| EP4737443A1 (en) * | 2023-05-24 | 2026-05-06 | Tanabe Pharma Corporation | Salt-inducible kinase inhibitory compound and pharmaceutical composition containing same |
-
2023
- 2023-09-13 US US18/466,034 patent/US20240124450A1/en active Pending
- 2023-09-18 CA CA3268028A patent/CA3268028A1/en active Pending
- 2023-09-18 FI FIEP23777048.2T patent/FI4590675T3/en active
- 2023-09-18 CR CR20250098A patent/CR20250098A/en unknown
- 2023-09-18 KR KR1020257012614A patent/KR20250070082A/en active Pending
- 2023-09-18 WO PCT/IB2023/059215 patent/WO2024062360A1/en not_active Ceased
- 2023-09-18 JP JP2025516096A patent/JP7826572B2/en active Active
- 2023-09-18 IL IL319012A patent/IL319012A/en unknown
- 2023-09-18 CN CN202380067401.6A patent/CN119948025A/en active Pending
- 2023-09-18 AU AU2023346248A patent/AU2023346248A1/en active Pending
- 2023-09-18 EP EP23777048.2A patent/EP4590675B1/en active Active
- 2023-09-18 PE PE2025000525A patent/PE20251177A1/en unknown
- 2023-09-20 AR ARP230102502A patent/AR130531A1/en unknown
- 2023-09-20 PY PY202302375863A patent/PY2375863A/en unknown
- 2023-09-20 TW TW112135857A patent/TW202421625A/en unknown
-
2025
- 2025-02-20 CL CL2025000479A patent/CL2025000479A1/en unknown
- 2025-03-13 CO CONC2025/0003311A patent/CO2025003311A2/en unknown
- 2025-03-20 DO DO2025000069A patent/DOP2025000069A/en unknown
- 2025-03-20 MX MX2025003324A patent/MX2025003324A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DOP2025000069A (en) | 2025-04-30 |
| JP2025532626A (en) | 2025-10-01 |
| JP7826572B2 (en) | 2026-03-09 |
| US20240124450A1 (en) | 2024-04-18 |
| CL2025000479A1 (en) | 2025-07-11 |
| AU2023346248A1 (en) | 2025-03-06 |
| FI4590675T3 (en) | 2026-07-22 |
| CN119948025A (en) | 2025-05-06 |
| CR20250098A (en) | 2025-05-05 |
| EP4590675B1 (en) | 2026-05-27 |
| MX2025003324A (en) | 2025-05-02 |
| PY2375863A (en) | 2024-05-20 |
| TW202421625A (en) | 2024-06-01 |
| KR20250070082A (en) | 2025-05-20 |
| CA3268028A1 (en) | 2024-03-28 |
| PE20251177A1 (en) | 2025-04-23 |
| AR130531A1 (en) | 2024-12-18 |
| EP4590675A1 (en) | 2025-07-30 |
| WO2024062360A1 (en) | 2024-03-28 |
| CO2025003311A2 (en) | 2025-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL318647A (en) | Heterocyclic compounds and uses thereof | |
| IL315099A (en) | Heterocyclic compounds and uses thereof | |
| IL316285A (en) | Heterocyclic compounds and uses thereof | |
| ES3065238T3 (en) | Heterocyclic pad4 inhibitors | |
| IL279173A (en) | New heterocyclic compounds as monoacylglycerol lipase inhibitors | |
| IL280762A (en) | New heterocyclic compounds as monoacylglycerol lipase inhibitors | |
| IL308421A (en) | Substituted heterocyclic compounds | |
| IL290508A (en) | Heterocyclic compounds as kinase inhibitors | |
| IL289594A (en) | New heterocyclic monoacylglycerol lipase (magl) inhibitors | |
| IL299664A (en) | Heterocyclic compounds | |
| ZA202212631B (en) | Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof | |
| IL314049A (en) | Parp7 inhibitors | |
| IL288936A (en) | Heterocyclic monoacylglycerol lipase (magl) inhibitors | |
| IL308422A (en) | Substituted heterocyclic compounds | |
| IL320185A (en) | Heterocyclic compound | |
| ZA202110352B (en) | New heterocyclic compounds | |
| CA3268028A1 (en) | Heterocyclic sik inhibitors | |
| EP4457224A4 (en) | Heterocyclic compounds | |
| EP4404927A4 (en) | Methanogen inhibitors | |
| PT3924351T (en) | Formulations comprising heterocyclic protein kinase inhibitors | |
| IL320814A (en) | Heterocyclic compound and use thereof | |
| EP4561975A4 (en) | Fto inhibitors | |
| IL313412A (en) | Heterocyclic compounds as kit kinase inhibitors | |
| SMT202500406T1 (en) | Tead inhibitors | |
| EP4263533C0 (en) | Erap inhibitors |